Showing results (11-20 of 281) with videos related to
Sort By:
Pageof 29
The British Journal of Cancer. Supplement|August 1, 1992
Disposition of antineoplastic agents in the very young childH L McLeod, M V Relling, W R Crom, et al.Science (New York, N.Y.)|October 16, 1999
Pharmacogenomics: translating functional genomics into rational therapeuticsW E Evans, M V RellingMolecular Pharmacology|May 1, 1990
Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family studyW E Evans, M V RellingClinical Pharmacokinetics|October 1, 1994
Clinical pharmacokinetics of paclitaxelD S Sonnichsen, M V RellingPharmacogenetics|December 1, 1991
Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizersW E Evans, M V RellingJournal of Chromatography|July 1, 1992
Automated high-performance liquid chromatographic assay for the determination of 7-ethoxycoumarin and umbelliferoneR R Evans, M V RellingBritish Journal of Clinical Pharmacology|July 15, 1998
Clinically relevant drug-drug interactions in oncologyH L McLeodPharmacology & Therapeutics|January 1, 1997
Therapeutic drug monitoring opportunities in cancer therapyH L McLeodPharmacogenetics|April 1, 1996
Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksC L Chen, Q Liu, M V RellingPharmacogenetics|October 1, 1991
Mephenytoin phenotyping: lack of haematologic effect and timing of urine collectionsM V Relling, D Ayers, R L HeidemanPageof 29